LYTIR

Insider · SEC Form 4 · Chief Medical Officer

Sarah Gheuens

Filed with the SEC as Gheuens Sarah; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: sold $1.4M of AGIO. Filed a median of 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $1.4M in total.Jul: Insider sales $151KAug: Insider sales $914KOct: Insider sales $371KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $1.4M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. AGIOSold: AGIOS PHARMACEUTICALS, INC. Oct 26, 2026 7,866 shares filed Oct 28, 2026 54,645 shares held directly after, as filed 10b5-1 plan filing $296K
  2. AGIOSold: AGIOS PHARMACEUTICALS, INC. Oct 22, 2026 500 shares filed Oct 23, 2026 54,645 shares held directly after, as filed 10b5-1 plan filing $19K
  3. AGIOSold: AGIOS PHARMACEUTICALS, INC. Oct 21, 2026 1,489 shares filed Oct 23, 2026 54,645 shares held directly after, as filed 10b5-1 plan filing $56K
  4. AGIOSold: AGIOS PHARMACEUTICALS, INC. Aug 4, 2026 30,000 shares filed Aug 6, 2026 54,645 shares held directly after, as filed 10b5-1 plan filing $914K
  5. AGIOSold: AGIOS PHARMACEUTICALS, INC. Jul 1, 2026 4,007 shares filed Jul 2, 2026 84,645 shares held directly after, as filed 10b5-1 plan filing $151K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • AGIO: option exercise or conversion (code M), 4 entries, Jul 1 to Oct 26, 2026
Code M
An exercise or conversion of a derivative security received from the company, such as stock options.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.